Modulating the tumor microenvironment to enhance efficacy of PARP inhibitors

被引：1
|
作者：
Mehibel, Manal
Xu, Jimmy
Diep, Anh
Thakkar, Kaushik
Li, Caiyun G.
Xiao, Yiren
Rankin, Erinn
Giaccia, Amato
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Stanford Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14715
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14715
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Podoplanin enhances tumor progression by modulating the tumor immune microenvironment
    Takagi, Satoshi
    Koike, Sumie
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2021, 112 : 727 - 727
  • [42] Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics
    Patel, Himadri
    Nilendu, Pritish
    Jahagirdar, Devashree
    Pal, Jayanta K.
    Sharma, Nilesh Kumar
    CANCER BIOLOGY & THERAPY, 2018, 19 (01) : 3 - 12
  • [43] Investigating the synergistic effects of immunotherapy and normalization treatment in modulating tumor microenvironment and enhancing treatment efficacy
    Harkos, Constantinos
    Stylianopoulos, Triantafyllos
    JOURNAL OF THEORETICAL BIOLOGY, 2024, 583
  • [44] Clinical efficacy of PARP inhibitors in breast cancer
    Karan Pandya
    Alyssa Scher
    Coral Omene
    Shridar Ganesan
    Shicha Kumar
    Nisha Ohri
    Lindsay Potdevin
    Bruce Haffty
    Deborah L. Toppmeyer
    Mridula A. George
    Breast Cancer Research and Treatment, 2023, 200 : 15 - 22
  • [45] PARP INHIBITION AND EFFICACY OF TOPOISOMERASE I INHIBITORS
    Pommier, Y.
    Das, B. B.
    Regairaz, M.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 19 - 19
  • [46] Clinical efficacy of PARP inhibitors in breast cancer
    Pandya, Karan
    Scher, Alyssa
    Omene, Coral
    Ganesan, Shridar
    Kumar, Shicha
    Ohri, Nisha
    Potdevin, Lindsay
    Haffty, Bruce
    Toppmeyer, Deborah L. L.
    George, Mridula A. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 200 (01) : 15 - 22
  • [47] Association of PARP inhibitors and docetaxel resistance through suppressing a tumor microenvironment-associated secretory program.
    Zhao, Song
    Coleman, Ilsa
    Coleman, Roger
    Nelson, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] PI 3-Kinase inhibitors enhance the synthetic lethality of Parp inhibitors
    Juvekar, Ashish P.
    Yadegarynia, Sina
    Hu, Hai
    Lyssiotis, Costas A.
    Liu, Hui
    Asara, John M.
    Scully, Ralph
    Cantley, Lewis C.
    Wulf, Gerburg M.
    CANCER RESEARCH, 2015, 75
  • [49] New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
    Guo, Gang
    Cui, Yan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [50] Preclinical efficacy of Tumor Treating Fields (TTFields) applied with PARP inhibitors or carboplatin in ovarian cancer
    Martinez-Conde, Antonia
    Ene, Hila
    Ben-Meir, Kerem
    Frechtel-Gerzi, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (01)
12345